Renqiang Ma
- Topics
- Asthma and respiratory diseases (10 papers)Allergic Rhinitis and Sensitization (6 papers)Epigenetics and DNA Methylation (6 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Renqiang Ma
45 papers receiving 596 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 272
- Cancer Research 144
- Immunology 121
- Oncology 115
- Pulmonary and Respiratory Medicine 111
Countries citing papers authored by Renqiang Ma
This map shows the geographic impact of Renqiang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renqiang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renqiang Ma more than expected).
Fields of papers citing papers by Renqiang Ma
This network shows the impact of papers produced by Renqiang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renqiang Ma. The network helps show where Renqiang Ma may publish in the future.
Co-authorship network of co-authors of Renqiang Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Renqiang Ma. A scholar is included among the top collaborators of Renqiang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renqiang Ma. Renqiang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 1 | |
| 5 | 20 | |
| 6 | 13 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 15 | |
| 10 | 68 | |
| 11 | 15 | |
| 12 | 18 | |
| 13 | 1 | |
| 14 | 20 | |
| 15 | 12 | |
| 16 | 3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells. | 15 |
| 17 | 4 | |
| 18 | 12 | |
| 19 | 5 | |
| 20 | 9 |
About Renqiang Ma
Renqiang Ma is a scholar working on Otorhinolaryngology, Immunology and Allergy and Complementary and alternative medicine, having authored 45 papers that have together received 605 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (10 papers), Allergic Rhinitis and Sensitization (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Immunology and Allergy (83 citations), Otorhinolaryngology (52 citations) and Cancer Research (144 citations). Renqiang Ma has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Weiping Wen, Huabin Li, Yihui Wen, Wei‐Zen Sun, Lin Chen, Xingmei Wu, Zhiwei Wang, Xi Luo, Hua‐Bin Li and Geng Xu. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.